No photo of Sara Feola
  • PL 56 (Viikinkaari 5)

    00014

    Finland

20172019
If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 317 Pharmacy

International and National Collaboration Publications and projects within past five years.

Publications 2017 2019

Open Access
File

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

Fontana, F., Fusciello, M., Groeneveldt, C., Capasso, C., Chiaro, J., Feola, S., Liu, Z., Mäkilä, E., Salonen, J., Hirvonen, J., Cerullo, V. & Santos, H. A., Jun 2019, In : ACS Nano. 13, 6, p. 6477-6490 14 p.

Research output: Contribution to journalArticleScientificpeer-review

Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy

Ylösmäki, L., Polini, B., Carpi, S., Martins, B., Smertina, E., Feola, S., Fusciello, M., Peltonen, K., Nieri, P., Ylösmäki, E. & Cerullo, V., 23 Oct 2019, In : PLoS One. 14, 10, p. e0224072

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site

Lopes, A., Feola, S., Ligot, S., Fusciello, M., Vandermeulen, G., Préat, V. & Cerullo, V., 10 Jul 2019, In : Journal for Immunotherapy of Cancer. 7, 1, 14 p., 174.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy

Falanga, A. P., Cerullo, V., Marzano, M., Feola, S., Oliviero, G., Piccialli, G. & Borbone, N., Mar 2019, In : Bioconjugate Chemistry. 30, 3, p. 572-582 11 p.

Research output: Contribution to journalArticleScientificpeer-review